We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Family Study in Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00418912
Recruitment Status : Unknown
Verified February 2008 by Sheba Medical Center.
Recruitment status was:  Recruiting
First Posted : January 5, 2007
Last Update Posted : February 15, 2008
Information provided by:
Sheba Medical Center

Brief Summary:

Schizophrenia is a severe mental illness which is considered to have, among other, a genetic etiology. One of the most efficient tools in genetic-psychiatry is the investigation of multiplex families.

The current study will identify patients of multiplex families and to map their family connections and the presence of mental illnesses among family members.

Condition or disease
Schizophrenia Family Genetics

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Family-Based
Time Perspective: Prospective
Study Start Date : March 2007
Estimated Primary Completion Date : December 2008
Estimated Study Completion Date : January 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inclusion Criteria:

  1. Schizophrenia
  2. Multiplex family
  3. Able to understand and sign the informed concent form.
  4. Hebrew speaker

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00418912

Contact: Raz Gross, MD 972-3-5303962 razg@gertner.health.gov.il
Contact: Michael Bunzel, MD 972-3-530

Psychiatric unit, Sheba Medical Center Recruiting
Tel Hashomer, Israel, 52621
Contact: Michael Bunzel, MD       chiba2@actcom.net.il   
Principal Investigator: Michael Bunzel, MD         
Seba Medical Center Recruiting
Tel Hashomer, Israel
Contact: Michael Bunzel, MD         
Principal Investigator: Michaael Bunzel, MD         
Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Raz Gross, MD Mental Health Epidemiology & Psychosocial Aspects of Illness, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer , Israel
Study Director: Michael Bunzel, MD Psychiatric Unit, Sheba Medical Center, Tel Hashomer, Israel

Responsible Party: Raz Gross, Head, Mental Health Epidemiology, The Gertner Institute for Epidemiology
ClinicalTrials.gov Identifier: NCT00418912     History of Changes
Other Study ID Numbers: SHEBA-06-4329-RG-CTIL
First Posted: January 5, 2007    Key Record Dates
Last Update Posted: February 15, 2008
Last Verified: February 2008

Additional relevant MeSH terms:
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders